Pharmaceutical industry innovation and developments /
Furkejuvvon:
| Searvvušdahkki: | |
|---|---|
| Eará dahkkit: | , |
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Hauppauge, N.Y. :
Nova Science,
c2011.
|
| Ráidu: | Business issues, competition and entrepreneurship series.
Pharmacology-research, safety testing, and regulation series. |
| Fáttát: | |
| Liŋkkat: | An electronic book accessible through the World Wide Web; click to view |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Geahča maid
Pharmaceutical industry innovation and developments /
Almmustuhtton: (2011)
Almmustuhtton: (2011)
The agile approach to adaptive research optimizing efficiency in clinical development /
Dahkki: Rosenberg, Michael J.
Almmustuhtton: (2010)
Dahkki: Rosenberg, Michael J.
Almmustuhtton: (2010)
The agile approach to adaptive research optimizing efficiency in clinical development /
Dahkki: Rosenberg, Michael J.
Almmustuhtton: (2010)
Dahkki: Rosenberg, Michael J.
Almmustuhtton: (2010)
Applications of microdialysis in pharmaceutical science
Almmustuhtton: (2011)
Almmustuhtton: (2011)
Applications of microdialysis in pharmaceutical science
Almmustuhtton: (2011)
Almmustuhtton: (2011)
Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
Almmustuhtton: (2007)
Almmustuhtton: (2007)
Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
Almmustuhtton: (2007)
Almmustuhtton: (2007)
Outsourcing clinical development strategies for working with CROs and other partners /
Almmustuhtton: (2006)
Almmustuhtton: (2006)
Outsourcing clinical development strategies for working with CROs and other partners /
Almmustuhtton: (2006)
Almmustuhtton: (2006)
ADME-enabling technologies for drug design and development
Almmustuhtton: (2012)
Almmustuhtton: (2012)
ADME-enabling technologies for drug design and development
Almmustuhtton: (2012)
Almmustuhtton: (2012)
Therapeutic targets modulation, inhibition, and activation /
Almmustuhtton: (2012)
Almmustuhtton: (2012)
Therapeutic targets modulation, inhibition, and activation /
Almmustuhtton: (2012)
Almmustuhtton: (2012)
Drugs : from discovery to approval /
Dahkki: Ng, Rick
Almmustuhtton: (2015)
Dahkki: Ng, Rick
Almmustuhtton: (2015)
Drugs : from discovery to approval /
Dahkki: Ng, Rick
Almmustuhtton: (2015)
Dahkki: Ng, Rick
Almmustuhtton: (2015)
Drug discovery practices, processes, and perspectives /
Almmustuhtton: (2013)
Almmustuhtton: (2013)
Drug discovery practices, processes, and perspectives /
Almmustuhtton: (2013)
Almmustuhtton: (2013)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
Almmustuhtton: (2012)
Almmustuhtton: (2012)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
Almmustuhtton: (2012)
Almmustuhtton: (2012)
Drug discovery and design medical aspects /
Almmustuhtton: (2002)
Almmustuhtton: (2002)
Drug discovery and design medical aspects /
Almmustuhtton: (2002)
Almmustuhtton: (2002)
Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
Almmustuhtton: (2004)
Almmustuhtton: (2004)
Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
Almmustuhtton: (2004)
Almmustuhtton: (2004)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
Almmustuhtton: (2008)
Almmustuhtton: (2008)
WHO Expert Committee on Specification for Pharmaceutical Preparations forty-second report.
Almmustuhtton: (2008)
Almmustuhtton: (2008)
Physiological pharmaceutics barriers to drug absorption /
Dahkki: Washington, Neena, 1961-
Almmustuhtton: (2001)
Dahkki: Washington, Neena, 1961-
Almmustuhtton: (2001)
Physiological pharmaceutics barriers to drug absorption /
Dahkki: Washington, Neena, 1961-
Almmustuhtton: (2001)
Dahkki: Washington, Neena, 1961-
Almmustuhtton: (2001)
Pharmaceutical blending and mixing /
Almmustuhtton: (2015)
Almmustuhtton: (2015)
Pharmaceutical blending and mixing /
Almmustuhtton: (2015)
Almmustuhtton: (2015)
Human drug targets : a compendium for pharmaceutical discovery /
Dahkki: Zanders, Edward D.
Almmustuhtton: (2016)
Dahkki: Zanders, Edward D.
Almmustuhtton: (2016)
Human drug targets : a compendium for pharmaceutical discovery /
Dahkki: Zanders, Edward D.
Almmustuhtton: (2016)
Dahkki: Zanders, Edward D.
Almmustuhtton: (2016)
Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
Almmustuhtton: (2008)
Almmustuhtton: (2008)
Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
Almmustuhtton: (2008)
Almmustuhtton: (2008)
Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
Almmustuhtton: (2010)
Almmustuhtton: (2010)
Evaluation of drug candidates for preclinical development pharmacokinetics, metabolism, pharmaceutics, and toxicology /
Almmustuhtton: (2010)
Almmustuhtton: (2010)
Development of therapeutic agents handbook
Almmustuhtton: (2012)
Almmustuhtton: (2012)
Development of therapeutic agents handbook
Almmustuhtton: (2012)
Almmustuhtton: (2012)
Manufacturing of pharmaceutical proteins : from technology to economy /
Dahkki: Behme, Stefan
Almmustuhtton: (2015)
Dahkki: Behme, Stefan
Almmustuhtton: (2015)
Manufacturing of pharmaceutical proteins : from technology to economy /
Dahkki: Behme, Stefan
Almmustuhtton: (2015)
Dahkki: Behme, Stefan
Almmustuhtton: (2015)
A mathematical approach to multilevel, multiscale health interventions pharmaceutical industry decline and policy response /
Dahkki: Wallace, Rodrick
Almmustuhtton: (2013)
Dahkki: Wallace, Rodrick
Almmustuhtton: (2013)